✦ LIBER ✦

The molecular basis of iron overload disorders and iron-linked anemias

✍ Scribed by Jerry Kaplan; Diane M. Ward; Ivana De Domenico

Book ID: 107619206
Publisher: Carden Jennings Publishing
Year: 2011
Tongue: English
Weight: 307 KB
Volume: 93
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-010-0760-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regulation of iron acquisition and stora

Regulation of iron acquisition and storage: consequences for iron-linked disorders

✍ De Domenico, Ivana; McVey Ward, Diane; Kaplan, Jerry 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 622 KB

Molecular and genetic basis of X-linked

Molecular and genetic basis of X-linked immunodeficiency disorders

✍ Jennifer M. Puck 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 1000 KB

Increased prooxidant action of hepatic c

Increased prooxidant action of hepatic cytosolic low-molecular-weight iron in experimental iron overload

✍ Robert S. Britton; Marco Ferrali; Christopher J. Magiera; Richard O. Recknagel; 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 634 KB

In the iron-loaded liver there may be an increase in the putative intracellular transit pool of iron, components of which could be catalytically active in stimulating lipid peroxidation. To study the levels of low-molecular-weight, catalytically active iron in the liver, cytosolic ultrafiltrates wer

Restoration of cardiac function by an ir

Restoration of cardiac function by an iron chelator, deferasirox, in a patient with aplastic anemia and cardiac iron overload

✍ Toru Kiguchi; Yoshikazu Ito; Yukihiko Kimura; Kazuma Ohyashiki 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 191 KB

Molecular mechanism of iron metabolism a

Molecular mechanism of iron metabolism and overload in chronic hepatitis C

✍ Masahiko Kaito 📂 Article 📅 2007 🏛 Springer Japan 🌐 English ⚖ 652 KB

The wide spectrum of hepatic iron overlo

The wide spectrum of hepatic iron overload

✍ Melania Manco; Anna Alisi; Antonella Mosca; Valerio Nobili 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 632 KB

Shorter duration and lower dose of peginterferon alfa-2a therapy results in inferior HBeAg seroconversion rates compared with the duration and dose of 48 weeks and 180 lg: NEPTUNE study.